La producción nacional de vacuna a virus Junin vivo atenuado (Candid #1)anti-fiebre hemorrágica argentina
Ambrosio, Ana María; Saavedra, María del Carmen; Riera, Laura Marisa; Fassio, Rubén Miguel.
Acta bioquím. clín. latinoam
; 40(1): 5-17, mar.2006. tab, graf, ilus
Artículo en Español | LILACS | ID: lil-508384
Documentos relacionados
Recent developments on Junin virus, a causative agent for Argentine haemorrhagic fever.
Promyelocytic leukemia protein is a restriction factor for Junín virus independently of Z matrix protein.
Restoration of virulence in the attenuated Candid#1 vaccine virus requires reversion at both positions 168 and 427 in the envelope glycoprotein GPC.
Potential and action mechanism of favipiravir as an antiviral against Junin virus.
Machupo Virus with Mutations in the Transmembrane Domain and Glycosylation Sites of the Glycoprotein Is Attenuated and Immunogenic in Animal Models of Bolivian Hemorrhagic Fever.
Glycoprotein N-linked glycans play a critical role in arenavirus pathogenicity.
Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody.
Alternative translation contributes to the generation of a cytoplasmic subpopulation of the Junín virus nucleoprotein that inhibits caspase activation and innate immunity.
[Co-circulation of Junín virus and other mammarenaviruses in a geographical area without confirmed cases of Argentine Hemorrhagic Fever].
[Argentine hemorrhagic fever].